DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $12,810,000 | -52.4% | 635,400 | -11.8% | 0.06% | -53.7% |
Q2 2021 | $26,885,000 | +73.4% | 720,400 | +18.8% | 0.12% | +68.1% |
Q1 2021 | $15,507,000 | -70.3% | 606,439 | -74.4% | 0.07% | -71.7% |
Q4 2020 | $52,128,000 | +164.2% | 2,366,225 | +120.3% | 0.25% | +58.8% |
Q1 2020 | $19,727,000 | -28.9% | 1,073,881 | -14.8% | 0.16% | +9.6% |
Q4 2019 | $27,763,000 | +40.4% | 1,260,216 | -6.7% | 0.15% | +62.2% |
Q1 2019 | $19,778,000 | +141171.4% | 1,350,000 | +224900.0% | 0.09% | – |
Q1 2015 | $14,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,930,237 | $85,373,000 | 50.34% |
RTW INVESTMENTS, LP | 5,029,462 | $48,082,000 | 4.58% |
EcoR1 Capital, LLC | 4,764,447 | $45,548,000 | 4.57% |
RA Capital Management | 3,933,489 | $37,604,000 | 2.88% |
Cormorant Asset Management, LP | 3,600,954 | $34,425,000 | 2.57% |
Omega Fund Management, LLC | 223,457 | $2,136,000 | 2.10% |
Ghost Tree Capital, LLC | 950,000 | $9,082,000 | 1.84% |
EMORY UNIVERSITY | 246,411 | $2,356,000 | 1.68% |
Trustees of Princeton University | 114,286 | $1,093,000 | 1.63% |
BRIDGER MANAGEMENT, LLC | 1,226,820 | $11,728,000 | 0.71% |